NBCD has emerged from Nordic Bioscience’s pioneering work in biomarker science and clinical research. Today, NBCD is a leading global full-service CRO, recognized world-wide for its expertise in clinical trial design and execution across osteoarthritis and other musculoskeletal disorders. Recent years, we are also recognizing the link between obesity and musculoskeletal disorders – integrating expertise from both areas to provide valuable insights.
“Built on a legacy of scientific innovation, NBCD is shaping the future of musculoskeletal drug development. With advanced study designs, strategic partnerships, and a consistent focus on quality, we are committed to accelerating clinical research for the next generation of treatments.”
Jeppe Ragnar Andersen, Chief Executive Officer
Delivering high-quality, science-led clinical trials in musculoskeletal clinical research
According to Global Data, we are the most experienced partner in osteoarthritis research
Providing global reach and dedicated research sites with extensive experience
